SHERRY CROWDER: Open Payments
NPI 1609057108 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$284 in 13 payments from 9 companies in 2025. Trend: 2023 $159 · 2024 $203 · 2025 $284
Food & beverage: $284
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $58 |
| E.R. Squibb & Sons, L.L.C. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| Teva Pharmaceuticals USA, Inc. | 1 | $35 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| ABBVIE INC. | 1 | $22 |
| Lundbeck LLC | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Alkermes, Inc. | 1 | $15 |
Products named: INVEGA SUSTENNA, COBENFY, CAPLYTA, REXULTI, AUSTEDO XR, INGREZZA, VRAYLAR, ARISTADA.
Industry payments across TX — which companies pay providers there.
